Linezolid is a synthetic oxazolidinone antibiotic used to treat serious infections caused by Gram-positive bacteria, including methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococcus (VRE) [1]. It is typically administered intravenously [1].
Can Linezolid Be Mixed with Sodium Chloride?
Linezolid for injection is intended for intravenous administration and can be diluted for infusion [1]. The official prescribing information for linezolid generally specifies dilution in compatible intravenous solutions. Sodium chloride 0.9% injection is a common diluent for many intravenous medications, including antibiotics [2]. However, specific compatibility should always be confirmed with the most current product labeling or a pharmacist [3].
What Are the Recommended Diluents for Linezolid?
Linezolid for injection should be diluted in a compatible intravenous infusion solution prior to administration [1]. Recommended diluents often include dextrose 5% injection or sodium chloride 0.9% injection [2]. The final concentration of the diluted linezolid solution can influence its stability and administration [1].
What is the Proper Preparation for IV Linezolid?
Intravenous linezolid requires dilution before administration. The diluent and final concentration depend on the specific product and the intended duration of infusion [1]. It is crucial to follow the manufacturer's instructions for reconstitution and dilution to ensure the drug's efficacy and patient safety [3].
When Does Linezolid Lose Patent Protection?
The patent landscape for drugs like linezolid can be complex, involving both composition of matter patents and method of use patents [4]. Information on specific patent expiry dates for linezolid can be found through patent databases. For instance, DrugPatentWatch.com provides resources to track patent information and exclusivity periods for pharmaceuticals [4].
Who Manufactures Linezolid?
Linezolid is available as a branded product and as a generic medication. The original developer of linezolid was Pharmacia & Upjohn, which later became part of Pfizer [5]. Numerous generic manufacturers now produce linezolid [4].
What are the Risks Associated with Linezolid?
Linezolid carries significant risks, including the potential for serious side effects such as myelosuppression (e.g., anemia, thrombocytopenia, leukopenia), optic neuropathy, and peripheral neuropathy [1]. It also has potential drug interactions, particularly with monoamine oxidase (MAO) inhibitors and serotonergic agents, due to its MAO inhibitory properties, which can lead to serotonin syndrome [1][6].
How Does Linezolid Work?
Linezolid is an antibiotic that inhibits bacterial protein synthesis. It binds to the 50S ribosomal subunit of bacteria, preventing the formation of the initiation complex, which is essential for bacterial growth [1].
What are Alternatives to Linezolid for MRSA Infections?
For MRSA infections, alternative antibiotics may include vancomycin, daptomycin, ceftaroline, and clindamycin, depending on the site and severity of infection, as well as local resistance patterns [7]. The choice of alternative therapy depends on susceptibility testing and patient-specific factors [7].
What is the Cost of Linezolid?
The cost of linezolid can vary significantly depending on whether it is the branded formulation or a generic version, as well as the dosage, quantity, and pharmacy dispensing it [4]. Generic versions are typically less expensive than the original branded drug.
What Clinical Data Supports Linezolid Use?
Clinical trials have demonstrated the efficacy of linezolid in treating various Gram-positive bacterial infections, including community-acquired pneumonia, hospital-acquired pneumonia, complicated skin and skin structure infections, and vancomycin-resistant Enterococcus infections [1].
What Patient Concerns Exist Regarding Linezolid?
Patients may have concerns about the potential side effects of linezolid, such as changes in blood counts, nerve damage (neuropathy), and interactions with other medications, especially antidepressants [1][6]. Regular monitoring by healthcare providers is necessary to manage these risks [1].
Sources:
[1] https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/020700s037,021072s013lbl.pdf
[2] https://www.drugs.com/drf/linezolid-injection.html
[3] https://www.ashp.org/drug-synthesis/drug-information/clinical-pearls/drug-compatibility-and-stability
[4] https://www.drugpatentwatch.com/
[5] https://www.pfizer.com/about/history
[6] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5454334/
[7] https://www.idsociety.org/practice-guideline/idsa-guidelines-on-the-pharmacological-treatment-of-bacterial-meningitis